ANTI VIRAL PHARMACEUTICAL PREVENT OR

Brand Owner (click to sort) Address Description
ARESTVYR SIGA Technologies, Inc. 660 Madison Avenue, Suite 1700 New York NY 10065 Anti-viral pharmaceutical to prevent and/or treat orthopoxvirus-related diseases;
TECOVYR SIGA Technologies, Inc. 660 Madison Avenue, Suite 1700 New York NY 10065 Anti-viral pharmaceutical to prevent or treat orthopoxvirus-related diseases;The wording TECOVYR has no meaning in a foreign language.;
TPOXX SIGA Technologies, Inc. 660 Madison Avenue, Suite 1700 New York NY 10065 Anti-viral pharmaceutical to prevent and/or treat orthopoxvirus-related diseases;
VARBLOCK SIGA Technologies, Inc. 660 Madison Avenue, Suite 1700 New York NY 10065 Anti-viral pharmaceutical to prevent and/or treat orthopoxvirus-related diseases;
ZYGAVIM SIGA Technologies, Inc. 660 Madison Avenue, Suite 1700 New York NY 10065 Anti-viral pharmaceutical to prevent and/or treat orthopoxvirus-related diseases;
 

Where the owner name is not linked, that owner no longer owns the brand

    
Technical Examples
  1. Therapeutically effective anti-viral compositions, useful especially against respiratory diseases caused or mediated by respiratory syncytial virus (RSV) are disclosed, wherein said compositions comprise at least one anti-RSV antibody, including high affinity antibodies, and an additional anti-inflammatory agent, especially corticosteroids, as well as anti-inflammatory antibodies, especially anti-interleukin-6. Also disclosed are methods of using such compositions to treat and/or prevent respiratory diseases. Such compositions may optionally contain other non-antibody anti-viral agents.